Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page
Leadership we all know we’ve had people leave in all areas of biologics division at record numbers. Some said they weren’t leaving for better pay or promotion but dysfunction and toxic state within division led people who had been fully committed to Ilumya to leave. An even bigger red flag is...
anonymous
Thread
biologicbiologics
harrassment
iluyma
sun biologics
sun pharma
sunshine law
Please will someone in leadership explain why current biologics applicants are being given higher range of base pay than first wave of hires back late 2018, Jan 2019?
Is this an act of desperation to get people to join?
Since salary discrepancies are widely known on Iluyma team (and...
anonymous
Thread
biologicbiologics
iluyma
psoriasis
salary
sun biologics
sun pharma
Let's see how long this "elite" group of reps hired to sell a NOT YET approved drug last.
First, Tildra's data is OLD and pathetically bad compared to established bilologics already out and definitely bad compared to newer IL-23s coming.
Ask your derm offices if they hear these new elite reps...